Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudying Health Outcomes After Treatment in Patients With Retinoblastoma
- Where
- Chicago, Cincinnati, Houston, Milwaukee, Minneapolis, Nashville, Philadelphia, St Louis
- People
- 900 worldwide
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT03932786 - No phaseTaking peopleCohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
- Where
- Nashville
- People
- 2,100
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT06482957 - No phaseTaking peopleSystematic Light Exposure in Pediatric Brain Tumor Survivors
- Where
- Houston
- Age
- 10 years to 18 years
- People
- 40
- Run by
- Baylor College of Medicine
See details and how to joinNCT05340881 - No phaseTaking peopleGonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
- Where
- Aurora
- Age
- Up to 30 years
- People
- 50
- Run by
- University of Colorado, Denver
See details and how to joinNCT06518746 - Phase 2Taking peopleInvestigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
- Where
- San Antonio
- People
- 25
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT04863950 - No phaseTaking peopleProspective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
- Where
- Dallas, Duarte, New Haven, Palo Alto, Pittsburgh
- People
- 500
- Run by
- RefleXion Medical
See details and how to joinNCT05406167 - Early phase 1Not yet taking people in United StatesSafety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
- Where
- Columbus
- Age
- Up to 30 years
- People
- 12
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05779930 - No phaseTaking peopleCIBMTR Research Database
- Where
- Milwaukee, Minneapolis
- People
- 99,999,999
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT01166009 - Phase 2Taking peopleA Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Where
- Aurora, Birmingham, Columbus, Salt Lake City, The Bronx, Washington D.C.
- Age
- 18 months to 40 years
- People
- 86
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05135975 - Phase 1/2Taking people64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Where
- Cincinnati, Duarte, Grand Rapids, Orange, Stanford
- Age
- 15 years and over
- People
- 26
- Run by
- Lantheus Medical Imaging
See details and how to joinNCT06298916 - No phaseTaking peopleEffects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
- Where
- Los Angeles
- Age
- 3 years and over
- People
- 140
- Run by
- Children's Hospital Los Angeles
See details and how to joinNCT06360718 - No phaseActive, not recruitingInterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- Where
- New York
- Age
- 3 years to 18 years
- People
- 4,900 worldwide
- Run by
- Columbia University
See details and how to joinNCT05929976 - No phaseTaking peopleInternational Rare Histiocytic Disorders Registry (IRHDR)
- Where
- Birmingham, Boston, Los Angeles, Madera, New York, Pittsburgh
- People
- 400 worldwide
- Run by
- The Hospital for Sick Children
See details and how to joinNCT02285582 - Phase 1/2Taking peopleEvaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
- Where
- Boston
- People
- 100
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06789601 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Chicago, New Haven
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - Phase 2Taking peopleChemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
- Where
- Birmingham, Gainsville, Vallhala
- Age
- 3 years to 39 years
- People
- 80
- Run by
- New York Medical College
See details and how to joinNCT05253495 - No phaseTaking peopleGeriatric Assessment and Technology Evaluation in Prostate Cancer
- Where
- Chicago
- Age
- 18 Minutes and over
- People
- 120
- Run by
- University of Chicago
See details and how to joinNCT06215508 - No phaseTaking peopleShwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
- Where
- Woburn
- People
- 8,000
- Run by
- Shwachman-Diamond Syndrome Alliance Inc
See details and how to joinNCT06999954 - Phase 1Taking peoplePhase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
- Where
- Columbus
- Age
- 12 months to 39 years
- People
- 18
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT04254419 - Phase 2Enrolling by invitationKIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
- Where
- Chicago, Los Angeles, Milwaukee, Nashville, Oakland, Palo Alto, Philadelphia, Salt Lake City, San Diego, San Francisco, Valhalla
- Age
- Up to 21 years
- People
- 50
- Run by
- Michael Pulsipher
See details and how to joinNCT02646839 - Phase 2Taking peopleThe EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Where
- Atlanta, Aurora, Birmingham, Boston, Buffalo, Charlotte, Duarte, Gainesville, Grand Rapids, Hackensack, Houston, Indianapolis, Kansas City, Los Angeles, Miami, New Haven, Oakland, Phoenix, San Antonio, San Francisco, St. Petersburg, Wilmington
- Age
- 1 year to 25 years
- People
- 95
- Run by
- Pediatric Transplantation & Cellular Therapy Consortium
See details and how to joinNCT03509961 - Phase 2Enrolling by invitationDonor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
- Where
- Aurora, Chicago, Cleveland, Columbus, Los Angeles, Milwaukee, Orlando, Phoenix, Salt Lake City, Seattle, St Louis, St. Petersburg, Valhalla
- Age
- 0 years to 25 years
- People
- 30
- Run by
- Michael Pulsipher
See details and how to joinNCT04836390 - No phaseTaking peopleUmbilical Vessel Catheterization Under ECG Monitoring and Guidance
- Where
- Palo Alto
- Age
- 1 day to 45 days
- People
- 150
- Run by
- Stanford University
See details and how to joinNCT03898596 - Phase 2Taking peopleA Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- Where
- Ann Arbor, Baltimore, Boston, Chicago, Durham, Houston, New York, Philadelphia, Portland, Salt Lake City, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 6 months to 25 years
- People
- 141 worldwide
- Run by
- Day One Biopharmaceuticals, Inc.
See details and how to joinNCT04775485 · EU 2024-510691-20-00 - No phaseTaking peopleαβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
- Where
- Columbus
- Age
- Up to 30 years
- People
- 50
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06082947